Nemaura Medical Gross Profit

The latest gross profit for NMRD is $-4.6M as of December 2023. That compares with $150K in the prior-year period — down 3154.9% year over year. That is below the Healthcare sector average of $64B. Investors often review this figure alongside Nemaura Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMRD's gross profit moved from $150K to $-4.6M — a 3154.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nemaura Medical's operating scale or balance-sheet position.

Against Healthcare companies, NMRD currently prints $-4.6M for gross profit, while the sector average sits near $64B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nemaura Medical's growth, margins, and balance sheet.

A gross profit figure of $-4.6M for NMRD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $64B. Explore the charts below for those layers of context.

After noting NMRD's gross profit ($-4.6M), review year-over-year change from $150K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.